This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at 1-888-411-7578.
The Philippines’ Food and Drug Administration (FDA) has warned against a fake Hepatitis C medicines circulating in Southeast Asia.
The FDA said the fake medicine brands include:
- Sofosbuvir + Ledipasvir (Ledso) 400 mg/ 90 mg capsule
- Daclatasvir (Dakavir) 60 mg capsule
It said that based on an advisory from the World Health Organization (WHO) the fake medicines have been circulating around South East Asia and “may reach the Philippine market.”
The FDA also warned those who will be caught selling the falsified medicine.
“The presence of these identified products pose potential danger or injury to the consuming public and the importation, selling or offering for sale of such is in direct violation of Republic Act No. 9711 or the Food and Drug Administration Act of 2009,” the agency added.
Pursuant to the warning first issued by WHO, the FDA said that the fake medicines were labeled as manufactured by Pharco Corporation based in Alexandria, Egypt.
Pharco released a statement denying the company produces such products.
– See more at: http://www.gmanetwork.com/news/story/568206/lifestyle/healthandwellness/fda-warns-against-fake-hepatitis-c-medicines#sthash.rqQCI4DS.dpuf